December 6, 2023
Shardul Amarchand Mangaldas advised Eris Lifesciences Limited (“Eris”) on its acquisition of Dermatology and Nephrology branded…
December 1, 2023
Shardul Amarchand Mangaldas advised DLF Limited on its partnership with Global Health Limited (“GHL” / “Medanta”)…
November 30, 2023
Shardul Amarchand Mangaldas advises Bain Capital Partners (“Bain Capital”) on acquiring a majority stake in Porus…
November 22, 2023
Shardul Amarchand Mangaldas advises RateGain Travel Technologies Limited on its Qualified Institutions Placement (QIP) of 9,331,259…
The Bar Council of India does not permit solicitation of work and advertising by legal practitioners and advocates. By accessing the Shardul Amarchand Mangaldas & Co. website (our website), the user acknowledges that:
Click here for important public notice from the Firm.